IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE

@article{Pao2005INVA,
  title={IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE},
  author={Li-heng Pao and Cheng Huei Hsiong and Oliver Yoa-Pu Hu and Jhi-Jung Wang and Shung-Tai Ho},
  journal={Drug Metabolism and Disposition},
  year={2005},
  volume={33},
  pages={395 - 402}
}
  • L. Pao, C. Hsiong, S. Ho
  • Published 1 March 2005
  • Biology, Medicine, Chemistry
  • Drug Metabolism and Disposition
A diester prodrug of nalbuphine, sebacoyl dinalbuphine (SDN), and its long-acting formulation are currently being developed to prolong the duration of nalbuphine. A comparative in vitro hydrolysis study was conducted for SDN in rat, rabbit, dog, and human blood. Both SDN and nalbuphine in blood or plasma were measured by high-performance liquid chromatography. The hydrolysis rates of SDN in blood were ranked as follows: rat > rabbit > human > dog. The rapid formation of nalbuphine in the blood… 
View on ASPET
dmd.aspetjournals.org
17 Citations
Background Citations
2
Methods Citations
1

Figures and Tables from this paper

17 Citations

In vitro and in vivo release of dinalbuphine sebacate extended release formulation: Effect of the oil ratio on drug release.
Pharmacokinetics of dinalbuphine sebacate and nalbuphine in human after intramuscular injection of dinalbuphine sebacate in an extended‐release formulation
TLDR
It took approximately 6 days for the complete release of DNS into the blood stream where DNS was rapidly hydrolysed to nalbuphine; suggesting a single injection of 150 mg DNS in the authors' extended-release formulation could provide long-lasting pain relief.
Simultaneous determination of nalbuphine and its prodrug sebacoly dinalbuphine ester in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in humans.
TLDR
The UPLC-MS/MS method was applied successfully to determine nalbuphine concentration in human plasma samples obtained from four Taiwanese volunteers receiving intramuscularly administration of sebacoyl dinal Buphine ester.
Topical application of sebacoyl dinalbuphine ester-loaded nanostructured lipid carriers alleviate pruritus in scratching mouse model.
Pharmacokinetics of nalbuphine hydrochloride after intravenous and intramuscular administration to Hispaniolan Amazon parrots (Amazona ventralis).
TLDR
In Hispaniolan Amazon parrots, nalbuphine appeared to have good bioavailability after IM administration and was rapidly cleared after IV and IM administration, requiring further investigation to determine the potential for clinical palliation of signs of pain in psittacine species.
Sebacoyl Dinalbuphine Ester Extended-release Injection for Long-acting Analgesia: A Multicenter, Randomized, Double-Blind, And Placebo-controlled Study in Hemorrhoidectomy Patients
TLDR
SDE injection demonstrated an extended analgesia effect, with a statistically significant reduction in pain intensity through 48 hours and 7 days after hemorrhoidectomy, according to VAS pain intensity scores.
A novel finding of nalbuphine-6-glucuronide, an active opiate metabolite, possessing potent antinociceptive effects: Synthesis and biological evaluation.
Prodrugs of triterpenoids and their derivatives.
Pro-soft Val-boroPro: a strategy for enhancing in vivo performance of boronic acid inhibitors of serine proteases.
TLDR
This "pro-soft" design of Val-boroPro is demonstrated with a construct activated by and targeted to DPPIV, including in vivo results showing improved antihyperglycemic activity and reduced toxicity relative to 1.
Prodrugs: design and clinical applications
TLDR
The most common functional groups that are amenable to prodrug design are described, and examples of prodrugs that are either launched or are undergoing human trials are highlighted.
...
...

References

SHOWING 1-10 OF 25 REFERENCES
High-performance liquid chromatographic method for the simultaneous determination of nalbuphine and its prodrug, sebacoyl dinalbuphine ester, in dog plasma and application to pharmacokinetic studies in dogs.
Oseltamivir: a clinical and pharmacological perspective
TLDR
Control trials comparing M2 ion channel inhibitor drugs and the new neuraminidase (NA) inhibitor agents are now needed to test the hypothesis that oseltamivir is a significant new agent for the prevention and treatment of influenza.
Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins.
Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802
TLDR
Oseltamivir is an ethyl ester prodrug of Ro 64-0802, a selective inhibitor of influenza virus neuraminidase, a suitable candidate for use in the prevention and treatment of influenza.
Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach.
TLDR
Naltrex one-3-acetylsalicylate hydrolyzed in human and dog plasma with a fast deacetylation step to naltrexone salicylates followed by a slower hydrolysis step tonaltrexOne.
Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine.
  • M. Mistry, J. Houston
  • Biology, Medicine
    Drug metabolism and disposition: the biological fate of chemicals
  • 1987
TLDR
The glucuronidation of morphine, naloxone, and buprenorphine by the liver and intestine has been assessed both in vitro and in vivo in the rat, and a comparative approach to correlate in vivo and in vitro data has advantages over the use of absolute drug characteristics.
Pharmacokinetic comparison of intravenous carbendazim and remote loaded carbendazim liposomes in nude mice.
The Disposition and Bioavailability of Intravenous and Oral Nalbuphine in Healthy Volunteers
TLDR
The low absolute bioavailability and prolonged elimination half‐life of nalbuphine associated with oral administration are likely due to extensive first‐pass metabolism and enterohepatic circulation, respectively.
Clinical Significance of Esterases in Man
TLDR
The concentration of aspirin relative to salicylate in the circulation may be affected by individual variation in esterase levels and the relative roles of the different esterases, and this may influence the overall pharmacological effect.
Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
TLDR
The pharmacokinetic properties of fosphenytoin permit the drug to serve as a well tolerated and effective alternative to parenteral phenytoin in the emergency and non-emergency management of acute seizures in children and adults.
...
...